Deals
OppFi Buys Arizona Bank for $130M at 1.2x Book
OppFi paid $130 million for BNCCORP and its BNC National Bank subsidiary, a cash-and-stock deal that values the Glendale, Arizona lender at 1.2 times its…
Deals — Page 5
M&A, fundraising, IPOs, and bankruptcies in regulated industries.
Deals
Adyen Bought Talon.One for $876M
Adyen paid €750 million ($876 million) in cash to buy Talon.
Deals
Paid $1.9B: Chiesi Bought KalVista and Its Approved Drug
Chiesi paid roughly $1.9 billion to buy KalVista Pharmaceuticals, an Italian pharma adding a commercial-stage biotech to its portfolio.
Deals
AbbVie Buys $1.45B Option on Kestrel's KRAS Program
AbbVie has secured an exclusive right to buy Kestrel Therapeutics for up to $1.45 billion, with the biotech required to hit unspecified development and…
Deals
Sun Pharma Bought Organon for $11.75B, Debt Included
Sun Pharma paid $11.75 billion, or $14 a share in cash, to buy Organon in a deal that positions the India-based generics maker among the world's biosimilar…
Deals
Lilly Bought Ajax for $2.3B on a JAK2 Resistance Bet
Eli Lilly paid up to $2.3 billion for Ajax Therapeutics on April 27, adding a Phase 1 myelofibrosis asset to a deal streak that's included Verve ($1B…
Deals
Lilly Bought In Vivo CAR-T as Sanofi Faces Reckoning
Eli Lilly bought an in vivo CAR-T biotech, terms undisclosed.
Deals
Google Commits $40 Billion to Anthropic at $350 Billion Valuation
Google put $10 billion into Anthropic on Friday at a $350 billion valuation, with another $30 billion committed contingent on performance milestones.
Deals
Paid $9B for Clario, Thermo Fisher Raises 2026 Revenue Guidance
Thermo Fisher paid $9 billion for Clario and got $30 million back in Q1.
Deals
Kailera Raises Record $625M IPO on Hengrui GLP-1 Pipeline
Kailera Therapeutics raised $625 million in a record IPO for an obesity biotech.
Deals
Regeneron Closes MFN Deal, Completing 17-Company White House Sweep
Regeneron signed the White House's most-favored-nation drug pricing deal Thursday, becoming the 17th and final company to do so — closing out a sweep that…
Deals
AbbVie Builds $1.4B Durham Campus, First in North Carolina
AbbVie has allocated $1.4 billion for a manufacturing campus in Durham, North Carolina, its first in the state, drawn from the company's $100 billion US…
Deals
Cut $1B Google Cloud Deal, Merck Targets HCP Engagement
Merck paid $1 billion to Google Cloud for access to its agentic AI platform, and the commercial team gets there first.
Deals
Buys Kashiv for $1.1B, Amneal Eyes $200B Biosimilar Market
Amneal paid $1.1 billion to buy Kashiv BioSciences: $750 million upfront in cash and equity at close, plus up to $350 million tied to pipeline milestones.
Deals
Forager Bids $1B for Repay at 75% Premium
Forager Capital Management offered $1 billion for Atlanta-based Repay Holdings at $4.80 a share, a 75% premium to the stock's 30-day volume-weighted average…
Deals
Paid $1.25B, Apollo Takes 13% of McKesson's Surgical Unit
Apollo Funds paid $1.25B for a 13% minority stake in McKesson's Medical/Surgical Solutions division, valuing MMS at roughly $13 billion.
Deals
Kelonia Sale Hands Venrock a 45-Fold Return on $20M
Venrock put $20 million into Kelonia Therapeutics.
Deals
Lilly Bets on Kelonia's In Vivo CAR-T
Lilly paid an undisclosed sum upfront for Kelonia Therapeutics on Monday, placing a large bet on in vivo CAR-T as its next platform priority.
Deals
Kailera Raises $625M in Record Biotech IPO on Nasdaq
Kailera Therapeutics raised $625 million Friday in a record-setting biotech IPO on the Nasdaq.
Deals
Kraken Paid $550M for Bitnomial's Triple CFTC License Stack
Kraken paid up to $550 million for Bitnomial, a derivatives firm, in a deal that closes by June.
